Blog Category: Certified Activity

The Role of Targeted Therapy in Health-related Quality of Life in Generalized Myasthenia Gravis

Generalized Myasthenia Gravis (gMG) is a chronic neuromuscular disorder that significantly impacts patients’ health-related quality of life (HRQoL). Despite advancements in disease management, many individuals with gMG continue to experience debilitating symptoms, persistent physical and mental fatigue, and challenges in …

Closing Gaps in Care: Re-framing Treatment Approaches from Reactive to Proactive in IBD

Inflammatory bowel disease (IBD) refers a group of chronic inflammatory disease affecting the intestines; namely, ulcerative colitis (UC) and Crohn’s disease (CD). IBD affects between 2.4 and 3.1 million adults in the United States, conferring substantial disease burden. Despite therapeutic …

Livestream: Pan-Viral Screening for HBV, HCV, and HIV in Diverse Practice Settings

Early detection and treatment of human immunodeficiency virus (HIV) and hepatitis B and C (HBV, HCV) are paramount to mitigating the damage associated with these diseases, thus allowing patients to live longer, healthier lives; but many patients do not receive …

Livestream: Digging Deeper into Abnormal Liver Test Results

Treatment for primary biliary cholangitis (PBC), a “common rare” chronic autoimmune disease of the intrahepatic bile ducts, is frequently hampered by missed or delayed diagnosis, as symptoms of PBC are often attributed to other conditions. This suboptimal recognition enables unchecked …

Digging Deeper into Abnormal Liver Test Results

Treatment for primary biliary cholangitis (PBC), a “common rare” chronic autoimmune disease of the intrahepatic bile ducts, is frequently hampered by missed or delayed diagnosis, as symptoms of PBC are often attributed to other conditions. This suboptimal recognition enables unchecked …

Livestream: The Life-long Care of Individuals with Lennox-Gastaut Syndrome: Strategies for Outcomes Optimization from Childhood Through Adulthood

Lennox-Gastaut syndrome (LGS) remains a challenging condition to understand, diagnose, and manage. Neuroscience/neurology clinicians, including nurses and nurse practitioners (NPs), encounter significant challenges in the management of patients with LGS, due to the severe symptoms and morbidities, diagnostic delays, and …

Bridging Gaps and Advancing Care in Sickle Cell Disease in the Context of Drug Therapy

Sickle cell disease (SCD) is a pathology caused by a mutative hemoglobin protein that produces rigid, sickle-shaped red blood cells (RBCs). Lifelong complications of SCD include acute veno-occlusive crises (VOCs), whose recurrence takes a significant toll on patients, and end-organ …